Literature DB >> 9445400

Analysis of the combined effect of two linear inhibitors on a single enzyme.

J J Martinez-Irujo1, M L Villahermosa, J Mercapide, J F Cabodevilla, E Santiago.   

Abstract

Different methods for studying the concurrent effects of two linear inhibitors on a single enzyme have been published, including the fractional product of Webb, the Yonetani-Theorell plot or the method of Chou and Talalay. Recently the use of combination plots has also been advocated for this purpose. We have evaluated the applicability of these methods and found that most of them depend on assumptions about the mechanism of action of the inhibitors. If the mechanism of action is not completely understood, or if some assumptions about the mechanism are unfounded, the parameters obtained may be meaningless. Even if these assumptions are correct, the interaction can be advantageously measured using an alternative representation that does not require a knowledge of the inhibition constants and allows experimental data to be retrieved from the plot. In other cases it is the interpretation of the results rather than the validity of the method that is misleading. A common mistake is to take the exclusivity of the effects of two inhibitors as exclusivity of their binding. We show that this assumption is seldom justified. In any case, it is possible to decide whether the combination of two or more inhibitors is more effective than their individual use by means of isobolographic analysis, even when no information about their mechanism of action is available.

Mesh:

Substances:

Year:  1998        PMID: 9445400      PMCID: PMC1219094          DOI: 10.1042/bj3290689

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  STUDIES ON LIVER ALCOHOL HYDROGENASE COMPLEXES. 3. MULTIPLE INHIBITION KINETICS IN THE PRESENCE OF TWO COMPETITIVE INHIBITORS.

Authors:  T YONETANI; H THEORELL
Journal:  Arch Biochem Biophys       Date:  1964-07-20       Impact factor: 4.013

2.  Complex formation of apo-enzyme, co-enzyme and substrate of D-amino acid oxidase. I. Kinetic analysis using indicators.

Authors:  K YAGI; T OZAWA
Journal:  Biochim Biophys Acta       Date:  1960-08-26

3.  Analysis of the interactions between an enzyme and multiple inhibitors using combination plots.

Authors:  E Asante-Appiah; W W Chan
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.

Authors:  G L Drusano; M Prichard; P A Bilello; J A Bilello
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 5.  Synergy, additivism and antagonism in immunosuppression. A critical review.

Authors:  M C Berenbaum
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

6.  Synergy between anions and farnesyldiphosphate competitive inhibitors of farnesyl:protein transferase.

Authors:  J D Scholten; K K Zimmerman; M G Oxender; D Leonard; J Sebolt-Leopold; R Gowan; D J Hupe
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

7.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

8.  The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.

Authors:  P Palatini
Journal:  Mol Pharmacol       Date:  1983-07       Impact factor: 4.436

9.  A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.

Authors:  T C Chou; P Talalay
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.486

10.  Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs.

Authors:  E L White; W B Parker; L J Ross; W M Shannon
Journal:  Antiviral Res       Date:  1993-12       Impact factor: 5.970

View more
  14 in total

1.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries.

Authors:  Max W Chang; Michael J Giffin; Rolf Muller; Jeremiah Savage; Ying C Lin; Sukwon Hong; Wei Jin; Landon R Whitby; John H Elder; Dale L Boger; Bruce E Torbett
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

3.  Inhibition sites in F1-ATPase from bovine heart mitochondria.

Authors:  Jonathan R Gledhill; John E Walker
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

4.  Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens.

Authors:  Amedeo De Nicolò; Marco Simiele; Andrea Calcagno; Adnan Mohamed Abdi; Stefano Bonora; Giovanni Di Perri; Antonio D'Avolio
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Antioxidant and antidiabetic activities of vanadium binding proteins purified from the sea squirt Halocynthia roretzi.

Authors:  Minoli Anuththara Gunasinghe; Sang Moo Kim
Journal:  J Food Sci Technol       Date:  2018-03-05       Impact factor: 2.701

6.  A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: compounds that compete with the template-primer.

Authors:  Carlos Cruchaga; Elena Anso; María Font; Virginia S Martino; Ana Rouzaut; Juan J Martinez-Irujo
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

7.  Drug interaction: focusing on response surface models.

Authors:  Soo-Il Lee
Journal:  Korean J Anesthesiol       Date:  2010-05-29

8.  Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.

Authors:  Dmitriy Minond; Mare Cudic; Nina Bionda; Marc Giulianotti; Laura Maida; Richard A Houghten; Gregg B Fields
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

9.  The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.

Authors:  Joy Y Feng; John K Ly; Florence Myrick; Derrick Goodman; Kirsten L White; Evguenia S Svarovskaia; Katyna Borroto-Esoda; Michael D Miller
Journal:  Retrovirology       Date:  2009-05-13       Impact factor: 4.602

10.  An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors.

Authors:  Katherine V Wendelsdorf; Zhuo Song; Yang Cao; David C Samuels
Journal:  PLoS Comput Biol       Date:  2009-01-09       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.